Comparative study of the efficacy and tolerability of dihydroartemisinin - piperaquine - trimethoprim versus artemether - lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroon, Ivory Coast and Senegal

BACKGROUND: The ACT recommended by WHO is very effective and well-tolerated. However, these combinations need to be administered for three days, which may limit adherence to treatment. The combination of dihydroartemisinin - piperaquine phosphate - trimethoprim (Artecom(®), Odypharm Ltd), which invo...

Descripción completa

Detalles Bibliográficos
Autores principales: Menan, Hervé, Faye, Oumar, Same-Ekobo, Albert, Oga, Agbaya Serge S, Faye, Babacar, Kiki Barro, Christiane P, Kuete, Thomas, N'diaye, Jean-Louis, Vicky, Ama-Moor, Tine, Rogert, Yavo, William, Kane, Dieynaba, Kassi, Kondo F, Kone, Moussa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146902/
https://www.ncbi.nlm.nih.gov/pubmed/21740570
http://dx.doi.org/10.1186/1475-2875-10-185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146902/
https://www.ncbi.nlm.nih.gov/pubmed/21740570
http://dx.doi.org/10.1186/1475-2875-10-185

Ejemplares similares